Amberley Stephens
Associate Principal Scientist, AstraZeneca
Amberley Stephens is listed as Associate Principal Scientist, AstraZeneca. Amberley spoke at Protein Sciences in Drug Discovery 2026 in November 2026 (speaker, “Industry Insider - Abselion - Quantification of his-tagged soluble and membrane proteins with Amperia - Amberley Stephens, AstraZeneca”). Speaks mainly at Hospitals and Health Care events.
Compiled from published conference agendas; not yet confirmed by Amberley. Is this you? Claim this profile.
- Sector: Hospitals and Health Care
Sessions at 1 conference
Protein Sciences in Drug Discovery 2026 10 November 2026
Others from AstraZeneca
- Paul Hudson President, AstraZeneca US and Executive Vice President, North America 5 sessions
- Shaun Grady Chair of AstraZeneca UK 4 sessions
- Olga Obrezanova Principal Scientist, Augmented Biologics Design 3 sessions
- Christof Jaeger Senior Director - Data Science & Modelling - Substance, Pharmaceutical Sciences 2 sessions
- Goran Dahl Associate Principal Scientist 2 sessions
- Melanie Leveridge Vice President Assays, Profiling & Cell Sciences 2 sessions
- Miranda Cooper Statistical Science Director 2 sessions
- Roger Kirby Senior Enterprise Architect 2 sessions
- Semra Kitchen Senior Director, Search & Evaluation, R&I 2 sessions
- Stefan Geschwindner Director Biophysics 2 sessions
- Andre Verhoek HTA & Modelling Science Director 1 session
- Andreas Heddini Vice President Medical and Regulatory Affairs, Nordics 1 session